Search results
Loren David Walensky. The Walensky laboratory focuses on the chemical biology of deregulated apoptotic and transcriptional pathways in cancer. Our goal is to develop an arsenal of new compounds-a “chemical toolbox”-to investigate and block protein interactions that cause cancer.
Email: loren_walensky@dfci.harvard.edu. Website: http://www.hms.harvard.edu/dms/bbs/fac/walensky.php Lab Size: 15-20. Summary. The Walensky laboratory focuses on the chemical biology of deregulated apoptotic and transcriptional pathways in cancer.
May 1, 2019 · Loren David Walensky | Department of Biological Chemistry & Molecular Pharmacology. Loren David Walensky, M.D., Ph.D. Professor of Pediatrics. 617-355-6369. Email. Publications View. Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice.
The Walensky laboratory focuses on the chemical biology of deregulated apoptotic and transcriptional pathways in cancer. Our goal is to develop an arsenal of new compounds-a “chemical toolbox”-to investigate and block protein interactions that cause cancer.
486. 2010. The challenge of drugging undruggable targets in cancer: lessons learned from targeting BCL-2 family members. GL Verdine, LD Walensky. Clinical cancer research 13 (24), 7264-7270. , 2007. 475. 2007. Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma.
25 Shattuck Street Boston, MA 02115 CSS Styles Code. fcf2c6b74fbdd7d4cf432a1c39a278f0
Loren D Walensky Harvard Medical School, Dana-Farber Cancer Institute & Children’s Hospital Boston, Mayer Building, Room 664, 450 Brookline Avenue, Boston, MA 02215, USA E-mail: loren_walensky@ dfci.harvard.edu Loren D Walensky is an Associate Professor of Pediatrics at Harvard Medical School, faculty member in the Department
